Clinical studies show: Mounjaro (tirzepatide) can help patients lose up to 22% of their body weight on average over 72 weeks Wegovy (semaglutide) produces an average 17% weight loss after 68 weeks under medical supervision Bariatric surgery such as a gastric sleeve or bypass can sometimes result in up to 70% total body weight loss within 1 to 2 years, but this depends on post-surgery lifestyle choices
Your doctor may need to adjust your GLP-1 dose, temporarily discontinue therapy, or investigate alternative causes for your symptoms
Fracture: A 2026 study of adults with type 2 diabetes found that patients who started a GLP-1 faced an 11 percent higher risk of fractures than those taking other diabetes medications
During supply issues The FDA permitted the sale of compounded semaglutide when there was a widespread shortage of FDA-approved versions, such as Ozempic and Wegovy
By modulating the release of certain neurotransmitters, DSIP can influence sleep patterns, particularly promoting slow-wave sleep, the most restorative stage of sleep
Its epidemiology is defined by a high prevalence, notable levels of disability and mortality, and often insufficient awareness (131, 132)